Evidence map›Paper›PMID 39857345›Full record

ArticleAntioxidants (Basel, Switzerland)2024

Drug Target Investigation of

Chuang Liu, Jun Dang, Minchen Wu

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chuang LiuSchool of Biotechnology, Jiangnan University, Wuxi 214122, China.
Jun DangKey Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810000, China.ORCID 0000-0003-4206-2587
Minchen WuSchool of Biotechnology, Jiangnan University, Wuxi 214122, China.

Funding

Special Project on Achievement Transformation of the Qinghai Provincial Science and Technology Department 2024-SF-145
6 · The paper itself

Abstract

The exploration of drug targets has always been a priority in new drug research, and this work is even more essential for natural active compounds.

Indexed as

drug affinity responsive target stabilitymolecular dynamics simulationN-p-coumaroyl-N’-caffeoylputrescinereverse virtual dockingSaxifraga tangutica

Identifiers

PMID39857345
PMCPMC11762362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.